Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer
|更新时间:2026-02-06
|
Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer
“The research progress in the field of breast cancer treatment was introduced. Multidisciplinary experts adopted the nominal group method to establish the consensus on drug treatment management of PI3K/Akt/mTOR inhibitors, which provides comprehensive guidance for pharmacists to carry out treatment management, helps to improve the treatment effect of patients, reduce the incidence of adverse reactions, and ensure the safety and effectiveness of drug use of patients.”
.Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer[J].ZHONGGUO YAOFANG,2025,36(11):1289-1300. DOI: 10.6039/j.issn.1001-0408.2025.11.01.
Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer